Wellington Management Group’s Pardes Biosciences PRDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-194,868
Closed -$1.41M – 2232
2022
Q1
$1.41M Sell
194,868
-13,010
-6% -$128K ﹤0.01% 1677
2021
Q4
$3.4M Buy
+207,878
New +$2.42M ﹤0.01% 1556

Other funds holding PRDS

Wellington Management Group's PRDS Position: Q2 2022 in Review

Wellington Management Group sold out of Pardes Biosciences (PRDS) in Q2 2022, closing a stake of 194,868 shares — an estimated $1.41M sold.

Wellington Management Group first reported a position in PRDS in Q4 2021 and held it in 2 quarters. The position peaked at $3.4M in Q4 2021. 69 funds tracked by Wall St. Rank hold PRDS as of Q2 2022.

  • Wellington Management Group reported no remaining Pardes Biosciences position as of Q2 2022 after selling out during the quarter.
  • Wellington Management Group sold 194,868 Pardes Biosciences shares in Q2 2022, an estimated $1.41M.
  • Wellington Management Group first reported a position in Pardes Biosciences in Q4 2021 and held it in 2 quarters.
  • Wellington Management Group's Pardes Biosciences position peaked at $3.4M in Q4 2021.
  • 69 funds tracked by Wall St. Rank held Pardes Biosciences as of Q2 2022.

Based on Wellington Management Group's 13F filing for Q2 2022, filed 15 Aug 2022.